Keywords: Alcon, Novartis, Nevanac, Macular edema, Scotland, SMC, Catarct surgery

Alcon's Nevanac accepted for NHS use in Scotland

Article | 12 November 2012

Print This

Ophthalmic specialist Alcon, a part of Swiss drug major Novartis (NOVN: VX), said yesterday that its Nevanac (nepafenac) 1mg/ml, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in